Newsletter Archive

1. 11.29.22 -- Enhancing Bioavailability: A Science-Based Technology Selection Process 11/29/2022

   11/29/22 Drug Discovery Online Newsletter

2. 11.29.22 -- De-Risking Your Bioconjugate's Development Path From Discovery To The Clinic 11/29/2022
   11/29/22 Drug Discovery Online Newsletter
3. 11.22.22 -- Effectively Managing Data In Process Development 11/22/2022
   11/22/22 Drug Discovery Online Newsletter
4. 11.17.22 -- Improve And Intensify Your Upstream Processes 11/17/2022

   11/17/22 Drug Discovery Online Newsletter

5. 11.15.22 -- Five Questions That Determine The Success Of Your PROTAC Programs 11/15/2022
   11/15/22 Drug Discovery Online Newsletter
6. 11.08.22 -- Molecular Biologic Formats Require Tailored CMC Solutions 11/8/2022

   11/08/22 Drug Discovery Online Newsletter

7. 11.08.22 -- Soluble Versus Insoluble Expression In Microbial Fermentation 11/8/2022
   11/08/22 Drug Discovery Online Newsletter
8. 11.07.22 -- Take Control Of Your Biomanufacturing Capacity And Timelines 11/7/2022

   11/07/22 Drug Discovery Online Newsletter

9. 11.01.22 -- End-To-End Development And Manufacturing: Small Volume Commercial Products 11/1/2022
   11/01/22 Drug Discovery Online Newsletter
10. 10.31.22 -- Choosing The Best Filtration Device For Your Specific Applications 10/31/2022

    10/31/22 Drug Discovery Online Newsletter